Clinical Trial Update: Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sitaxsentan for airway remodeling in severe asthma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Sitaxsentan (sitaxsentan)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Effect of Sitaxsentan on Airway Remodeling in Severe Asthma | Phase 2 | Status: TERMINATED